Shell Asset Management CO Biogen Inc. Transaction History

Shell Asset Management CO

$2.2 Billion
Q1 2024

A detailed history of Shell Asset Management CO transactions in Biogen Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 4,055 shares of BIIB stock, worth $704,718. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,055

Previous 4,324 6.22%

Holding current value

$704,718

Previous $932,000 0.86%

% of portfolio

0.04%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 31, 2024	SELL	$212.02 - $267.71 $57,033 - $72,013	-269 Reduced 6.22%	4,055 $940,000
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $665,318 - $840,073	-3,138 Reduced 42.05%	4,324 $932,000
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $540,893 - $651,094	2,430 Added 48.29%	7,462 $1.93 Million
Q3 2023 Nov 08, 2023	SELL	$253.3 - $285.89 $36,221 - $40,882	-143 Reduced 2.76%	5,032 $1.29 Million
Q2 2023 Jul 28, 2023	SELL	$275.25 - $318.06 $199,831 - $230,911	-726 Reduced 12.3%	5,175 $1.47 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $6,157 - $7,016	-24 Reduced 0.41%	5,901 $1.64 Million
Q4 2022 Feb 07, 2023	SELL	$252.44 - $306.72 $330,443 - $401,496	-1,309 Reduced 18.1%	5,925 $1.64 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $275,291 - $379,602	-1,414 Reduced 16.35%	7,234 $1.93 Million
Q2 2022 Aug 09, 2022	SELL	$187.54 - $223.02 $9,752 - $11,597	-52 Reduced 0.6%	8,648 $1.76 Million
Q1 2022 May 04, 2022	SELL	$193.77 - $244.14 $65,494 - $82,519	-338 Reduced 3.74%	8,700 $1.83 Million
Q4 2021 Feb 09, 2022	BUY	$223.92 - $287.77 $478,293 - $614,676	2,136 Added 30.95%	9,038 $2.17 Million
Q3 2021 Nov 04, 2021	SELL	$282.99 - $369.05 $14,432 - $18,821	-51 Reduced 0.73%	6,902 $1.95 Million
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $1.4 Million - $2.24 Million	-5,408 Reduced 43.75%	6,953 $2.41 Million
Q1 2021 May 10, 2021	SELL	$242.95 - $284.63 $615,392 - $720,967	-2,533 Reduced 17.01%	12,361 $3.46 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $591,595 - $890,497	2,504 Added 20.21%	14,894 $3.65 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $8,737 - $10,088	-33 Reduced 0.27%	12,390 $3.52 Million
Q2 2020 Aug 10, 2020	BUY	$258.66 - $342.55 $795,379 - $1.05 Million	3,075 Added 32.89%	12,423 $3.32 Million
Q1 2020 May 11, 2020	SELL	$268.85 - $341.04 $581,253 - $737,328	-2,162 Reduced 18.78%	9,348 $2.96 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $20,685 - $28,582	-94 Reduced 0.81%	11,510 $3.42 Million
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $206,351 - $227,458	-941 Reduced 7.5%	11,604 $2.71 Million
Q1 2019 May 09, 2019	SELL	$216.71 - $338.96 $113,772 - $177,954	-525 Reduced 4.02%	12,545 $2.97 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $791,497 - $1 Million	-2,842 Reduced 17.86%	13,070 $3.93 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $12,327 - $16,120	42 Added 0.26%	15,912 $5.62 Million
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $506,026 - $603,078	1,965 Added 14.13%	15,870 $4.61 Million
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $2.54 Million - $3.59 Million	-9,769 Reduced 41.26%	13,905 $3.81 Million
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $1.02 Million - $1.14 Million	3,319 Added 16.31%	23,674 $7.54 Million
Q3 2017 Oct 20, 2017	SELL	$281.15 - $329.69 $5.21 Million - $6.11 Million	-18,527 Reduced 47.65%	20,355 $6.37 Million
Q3 2017 Oct 18, 2017	BUY	$281.15 - $329.69 $10.9 Million - $12.8 Million	38,882	38,882 $12.9 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Biogen Inc. Transaction History